Considerations for Treatment of Endocrine Dysfunction in COVID-19
Review authors summarized preliminary research on COVID-19 and past research on SARS-CoV-1 regarding their relationship with endocrine dysfunction.
All articles by Morgan E. Meissner
Effects of Insulin Sensitizers on Hormonal and Metabolic Parameters in PCOS
Combination therapy with insulin sensitizers may be superior to monotherapy for improvement of hyperandrogenemia and menstrual recovery in polycystic ovary syndrome.
Estimates of Live Birth Rates for Second ART-Conceived Children
Researchers examined factors associated with returning to the use of assisted reproductive therapy for a second child and cycle-specific and cumulative live birth rates.
Weighing the Effects of Immunosuppression for Hyperinflammation in COVID-19
The effects of reducing hyperinflammation by immunosuppression has been discussed in this editorial.
Overweight or Obese BMI in Preschool Associated With Increased Fracture Risk
Overweight and obesity during preschool age are associated with increased risk for fracture in childhood.
Tall, Lean Body Size in Childhood Linked to Risk for Endometriosis
Lean and tall girls are at increased risk for endometriosis, but not adenomyosis, in adulthood.
High AMH Levels Associated With Preterm Delivery in Women With PCOS
The researchers aimed to identify the association between serum AMH levels and preterm delivery in women with PCOS who underwent in vitro fertilization.
Metabolic Syndrome Severity Associated With Sleep Quality in Adolescents With PCOS
Metabolic syndrome is associated with poorer sleep in girls with polycystic ovary syndrome and obesity.
How Does Health Status Affect Insulin Use in Older Individuals With Type 2 Diabetes?
Among older individuals with type 2 diabetes, insulin use is least prevalent in those in good health, and discontinuation of insulin treatment is most likely in healthier patients.
Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause
The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.
- Loading...
Loading...
Next post in NAMS 2019 Annual Meeting
Loading... 
Loading...